Target
Phospholipase A2
Ligand
BDBM72097
Substrate
n/a
Meas. Tech.
Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay
IC50
3930±n/a nM
Citation
 PubChem, PC Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay PubChem Bioassay (2011)[AID] 
Target
Name:
Phospholipase A2
Synonyms:
Group IB phospholipase A2 | PA21B_HUMAN | PLA2 | PLA2A | PLA2G1B | PPLA2 | Phosphatidylcholine 2-acylhydrolase 1B | Phospholipase A2 (PLA2) | Phospholipase A2 group 1B | phospholipase A2 precursor
Type:
Protein
Mol. Mass.:
16364.13
Organism:
Homo sapiens (Human)
Description:
P04054
Residue:
148
Sequence:
MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS
  
Inhibitor
Name:
BDBM72097
Synonyms:
1-(3-chlorobenzyl)-2-keto-6-(trifluoromethyl)nicotinamide | 1-(3-chlorobenzyl)-2-oxo-6-(trifluoromethyl)-1,2-dihydro-3-pyridinecarboxamide | 1-[(3-chlorophenyl)methyl]-2-oxidanylidene-6-(trifluoromethyl)pyridine-3-carboxamide | 1-[(3-chlorophenyl)methyl]-2-oxo-6-(trifluoromethyl)-3-pyridinecarboxamide | 1-[(3-chlorophenyl)methyl]-2-oxo-6-(trifluoromethyl)pyridine-3-carboxamide | MLS000325556 | SMR000169863 | cid_3849988
Type:
Small organic molecule
Emp. Form.:
C14H10ClF3N2O2
Mol. Mass.:
330.69
SMILES:
NC(=O)c1ccc(n(Cc2cccc(Cl)c2)c1=O)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: